Preparation, Characterization, and Scale-up of Ketoconazole with Enhanced Dissolution and Bioavailability
| Autor: | James E. Hitt, Shakil A. Saghir, Brian D. Scherzer, Dan A. Markham, Gary B. Kupperblatt, Jonathan C. Evans, Edmund J. Elder |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Male
Antifungal Agents Materials science Drug Storage Biological Availability Pharmaceutical Science In Vitro Techniques Dosage form Random Allocation Tableting Dogs Drug Stability X-Ray Diffraction Drug Discovery Animals Chemical Precipitation Technology Pharmaceutical Particle Size Solubility Dissolution Pharmacology Active ingredient Cross-Over Studies Aqueous solution Chromatography Precipitation (chemistry) Methanol Organic Chemistry Bioavailability Ketoconazole Microscopy Electron Scanning Solvents Powders Tablets |
| Zdroj: | Drug Development and Industrial Pharmacy. 33:755-765 |
| ISSN: | 1520-5762 0363-9045 |
| DOI: | 10.1080/03639040601031882 |
| Popis: | Many new molecular entities targeted for pharmaceutical applications face serious development challenges because of poor water solubility. Although particle engineering technologies such as controlled precipitation have been shown to enhance aqueous dissolution and bioavailability of poorly water soluble active pharmaceutical ingredients, the data available are the results of laboratory-scale experiments. These technologies must be evaluated at larger scale to ensure that the property enhancement is scalable and that the modified drugs can be processed on conventional equipment. In experiments using ketoconazole as the model drug, the controlled precipitation process was shown to produce kg-scale modified drug powder with enhanced dissolution comparable to that of lab-scale powder. Ketoconazole was demonstrated to be stable throughout the controlled precipitation process, with a residual methanol level below the ICH limit. The modified crystalline powder can be formulated, and then compressed using conventional high-speed tableting equipment, and the resulting tablets showed bioavailability more than double that of commercial tablets. When appropriately protected from moisture, both the modified powder and tablets prepared from the modified powder showed no change in dissolution performance for at least 6 months following storage at accelerated conditions and for at least 18 months following storage at room temperature. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |